Stifel Financial Corp Spero Therapeutics, Inc. Transaction History

Stifel Financial Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$1.55 - $2.12 $2,697 - $3,688	-1,740 Reduced 13.91%	10,766 $18,000
Q3 2022 Nov 14, 2022	SELL	$0.68 - $2.2 $9,330 - $30,188	-13,722 Reduced 52.32%	12,506 $25,000
Q2 2022 Aug 15, 2022	SELL	$0.74 - $7.44 $8,510 - $85,560	-11,500 Reduced 30.48%	26,228 $19,000
Q1 2022 May 13, 2022	BUY	$7.87 - $15.15 $61,716 - $118,806	7,842 Added 26.24%	37,728 $328,000
Q4 2021 Feb 14, 2022	SELL	$13.09 - $18.77 $228,158 - $327,161	-17,430 Reduced 36.84%	29,886 $479,000
Q3 2021 Nov 15, 2021	SELL	$13.03 - $19.51 $22,841 - $34,201	-1,753 Reduced 3.57%	47,316 $871,000
Q2 2021 Aug 13, 2021	BUY	$12.22 - $15.79 $6,110 - $7,895	500 Added 1.03%	49,069 $685,000
Q1 2021 May 14, 2021	SELL	$13.23 - $21.48 $5,543 - $9,000	-419 Reduced 0.86%	48,569 $714,000
Q4 2020 Feb 12, 2021	SELL	$11.65 - $22.07 $14,912 - $28,249	-1,280 Reduced 2.55%	48,988 $950,000
Q3 2020 Nov 16, 2020	BUY	$8.96 - $14.12 $67,029 - $105,631	7,481 Added 17.48%	50,268 $561,000
Q2 2020 Aug 14, 2020	SELL	$7.27 - $14.18 $8,789 - $17,143	-1,209 Reduced 2.75%	42,787 $579,000
Q1 2020 May 14, 2020	BUY	$5.27 - $10.41 $73,616 - $145,417	13,969 Added 46.52%	43,996 $355,000
Q4 2019 Feb 13, 2020	BUY	$9.46 - $12.16 $161,557 - $207,668	17,078 Added 131.89%	30,027 $289,000
Q3 2019 Nov 13, 2019	BUY	$9.01 - $12.55 $116,670 - $162,509	12,949 New	12,949 $137,000

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $33.3M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.